RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Multi-trait genome-wide association study of opioid addiction
OPRM1 and beyond
Gaddis, N. C., Mathur, R., Marks, J., Zhou, L., Quach, B. C., Waldrop, A., Levran, O., Agrawal, A., Randesi, M., Adelson, M., Jeffries, P. W., Johnson, E. C., Martin, N. G., Degenhardt, L., Montgomery, G. W., Wetherill, L., Lai, D., Bucholz, K., Foroud, T., ... Johnson, E. O. (2021). Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2021.09.13.21263503
Opioid addiction (OA) has strong heritability, yet few genetic variant associations have been robustly identified. Only rs1799971, the A118G variant in OPRM1, has been identified as a genome-wide significant association with OA and independently replicated. We applied genomic structural equation modeling to conduct a GWAS of the new Genetics of Opioid Addiction Consortium (GENOA) data and published studies (Psychiatric Genomics Consortium, Million Veteran Program, and Partners Health), comprising 23,367 cases and effective sample size of 88,114 individuals of European ancestry. Genetic correlations among the various OA phenotypes were uniformly high (rg > 0.9). We observed the strongest evidence to date for OPRM1: lead SNP rs9478500 (p=2.56×10−9). Gene-based analyses identified novel genome-wide significant associations with PPP6C and FURIN. Variants within these loci appear to be pleiotropic for addiction and related traits.